Effect of Evolocumab on Saphenous Vein Graft Patency Following Coronary Artery Bypass Surgery

NCT03900026 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

782

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Bypass Graft Surgery
Atherosclerosis
Vein Occlusion

Interventions

DRUG: Evolocumab
OTHER: Placebo

Sponsor

Unity Health Toronto

Collaborators

[object Object]